» Articles » PMID: 25331535

Evaluation of High-sensitivity Serum CRP Levels Compared to Markers of Airway Inflammation and Allergy As Predictors of Methacholine Bronchial Hyper-responsiveness in Children

Overview
Journal Lung
Specialty Pulmonary Medicine
Date 2014 Oct 22
PMID 25331535
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Bronchial hyper-responsiveness assessed by the methacholine challenge test (MCT) may aid in the diagnosis of asthma, while a negative MCT can help in excluding the diagnosis. Laboratory measures that predict the results of MCT are expected to reduce the number of procedures. We evaluated the capacity of serum high-sensitivity C-reactive protein (hs-CRP) to predict positive or negative MCT in school-aged children and compared it to a marker of airway inflammation, fractional exhaled nitric oxide (FeNO), and markers of allergic sensitization, immune globulin E (IgE) and peripheral blood eosinophils.

Patients And Methods: Children aged 6-18 years referred for MCT were included in the study. The results of the MCT were compared to hs-CRP levels and FeNO levels, IgE, and peripheral blood eosinophil counts.

Results: Of the 131 children assessed, 63 (48 %) patients had positive MCTs (Group I), and 68 (52 %) had negative MCTs (Group II). The best cut-off values to predict a positive MCT by receiver-operating characteristic curves were: 23 ppb for FeNO, 120 IU/mL for IgE, and 500/mL for eosinophils; no cut-off value was found for hs-CRP. The odds ratio for a positive MCT with the above cut-off points were 2.43 (1.05-5.61) for FeNO, 2.4 (1.01-5.74) for IgE, 3.32 (1.13-9.75) for eosinophils, and NS for hs-CRP. No correlation was found between hs-CRP and FeNO, IgE, or eosinophil levels.

Conclusions: hs-CRP levels were not helpful, while FeNO, IgE, and eosinophils were useful in the prediction of methacholine bronchial hyper-responsiveness in our group of children.

Citing Articles

High-Sensitivity C-Reactive Protein Can Reflect Small Airway Obstruction in Childhood Asthma.

Ko A, Kim Y, Sol I, Kim M, Yoon S, Kim K Yonsei Med J. 2016; 57(3):690-7.

PMID: 26996570 PMC: 4800360. DOI: 10.3349/ymj.2016.57.3.690.

References
1.
Deraz T, Kamel T, El-Kerdany T, El-Ghazoly H . High-sensitivity C reactive protein as a biomarker for grading of childhood asthma in relation to clinical classification, induced sputum cellularity, and spirometry. Pediatr Pulmonol. 2011; 47(3):220-5. DOI: 10.1002/ppul.21539. View

2.
Wilkinson T, Donaldson G, Johnston S, Openshaw P, Wedzicha J . Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006; 173(8):871-6. DOI: 10.1164/rccm.200509-1489OC. View

3.
Takemura M, Matsumoto H, Niimi A, Ueda T, Matsuoka H, Yamaguchi M . High sensitivity C-reactive protein in asthma. Eur Respir J. 2006; 27(5):908-12. DOI: 10.1183/09031936.06.00114405. View

4.
Sandrini A, Taylor D, Thomas P, Yates D . Fractional exhaled nitric oxide in asthma: an update. Respirology. 2009; 15(1):57-70. DOI: 10.1111/j.1440-1843.2009.01616.x. View

5.
Bakirtas A, Turktas I . Determinants of airway responsiveness to adenosine 5'-monophosphate in school-age children with asthma. Pediatr Pulmonol. 2006; 41(6):515-21. DOI: 10.1002/ppul.20355. View